• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Samsung Health Integrates with WellDoc’s Consumer Diabetes Health App

by Fred Pennic 04/19/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

WellDoc Unveils Consumer Diabetes Health App, BlueStar C to Help Truckers with Diabetes Management

Today, WellDoc announced it has entered a joint commercial partnership agreement with Samsung. The enhanced partnership with WellDoc gives Samsung an opportunity to serve global consumers who are ready to embrace the combined health innovations that both companies plan to offer. Samsung also becomes a distribution channel for WellDoc.

The companies will integrate WellDoc’s newly-released consumer diabetes health app, BlueStar® C, with the recently launched Samsung Health, a mobile one-stop shop for health and fitness, and with Samsung Gear, including smart watches and fitness trackers.

BlueStar C is a diabetes health tool designed to aid individuals living with diabetes in managing their chronic condition and is the consumer version of WellDoc’s suite of diabetes products. It shares many of the same key features of the company’s therapeutic product offerings, but with a distinct lifestyle focus.

Specifically, BlueStar C offers:

– individualized, real-time support for users in their day-to-day diabetes self-care;

– easy tracking of blood glucose readings, food, medications, physical activity and sleep

– videos and other resources to help improve daily lifestyle choices

– a progress report that can be shared with family members or health care teams.

“Samsung is both an investor in – and an ideal partner for – WellDoc, so it is incredibly rewarding for us to take our collaboration to the next level. Through this commercial agreement, Samsung becomes a distribution channel for WellDoc, and Samsung Health serves as a platform for BlueStar C,” said Kevin McRaith, CEO of WellDoc.

WellDoc also has important collaborations with other leading healthcare and technology companies, such as LifeScan, one of the Johnson & Johnson Diabetes Care Companies, the American Association of Diabetes Educators (AADE), and the Ontario Telemedicine Network (OTN). 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: diabetes, diabetes app, Diabetes Management Platform, Digital Diabetes Platform, Samsung, Type 2 Diabetes, WellDoc, WellDoc BlueStar

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |